Clostridium difficile, atopy and wheeze during the first year of life

Pediatric Allergy and Immunology

Volumn 13, Issue 5, 2002, Pages 357-360

  Woodcock, Ashley ^a   Moradi, Mohammad ^b   Smillie, Frazer I ^a   Murray, Clare S ^a   Burnie, James P ^b   Custovic, Adnan ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Asthma; Atopy; Clostridium difficile; Intestinal microflora

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ATOPY; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; WHEEZING; ABNORMAL RESPIRATORY SOUND; ANTIBODY SPECIFICITY; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FOLLOW UP; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; INFANT WELFARE; METABOLISM; PSEUDOMEMBRANOUS COLITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; SKIN TEST;

ANTIBODY SPECIFICITY; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; COHORT STUDIES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN G; INFANT; INFANT WELFARE; MALE; PROSPECTIVE STUDIES; RECURRENCE; RESPIRATORY SOUNDS; RISK FACTORS; SKIN TESTS;

EID: 1842870004     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2002.01066.x     Document Type: Article

References (10)

1. Sepp E, Julge V, Vasar M, Naaber P, Bjorksten B, Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Pediatr 1997: 86: 956-61.
2. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999: 29: 342-6.
3. Custovic A, Simpson Bm, Simpson A, Hallam C, Craven M, Brutsche M, Woodcock A. Manchester Asthma and Allergy Study: Low allergen environment can be achieved and maintained during pregnancy and in early life. J Allergy Clin Immunol 2000: 105: 252-8.
4. Custovic A, Simpson BM, Simpson A, Kissen P, Woodcock A. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during the first year of life: A randomised trial. Lancet 2001: 358: 188-93.
5. Matricardi PM, Rosmini F, Ferigno L, et al. Cross-sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997: 314: 999-1003.
6. Bottcher M, Sandin A, Norin E, Midtvedt T, BJORKSTEN B. Microflora associated characteristics in faeces from allergic and non-allergic children. Clin Exp Allergy 2000: 30: 590-6.
7. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. J Allergy Clin Immunol 2001: 107: 129-34.
8. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001: 108: 516-20.
9. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001: 357: 1076-9.
10. H2 dominant immunity in mice. J Allergy Clin Immunol 2001: 107: 153-9.